Startups
Kallisio creates patient-specific, oral-cavity–based solutions to deliver safer, targeted treatments across multiple care areas.
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 14, 2026 | Kallisio Moves to Close Adoption Gap for 3D Printed Head and Neck Cancer Device | Personalized cancer medtech Kallisio has launched an expanded access program aimed at connecting head and neck cancer patients with Stentra, its FDA-cleared, custom-fit 3D printed intraoral device used during radiation therapy. The program ... |
Reviews 0
FAQ about Kallisio
What has the press written about Kallisio?
Parsers VC has collected 2 articles mentioning Kallisio, among them “Kallisio Moves to Close Adoption Gap for 3D Printed Head and Neck Cancer Device” (Sep 14, 2026).
Is Kallisio still active?
Yes, Kallisio is active; its latest activity on Parsers VC dates from Oct 2, 2026.